Kyowa Kirin Korea Co., Ltd.

Quick facts

Phase 2 pipeline

• AMG531 · Hematology
  AMG531 is a thrombopoietin receptor agonist.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kyowa Kirin Korea Co., Ltd. portfolio CI brief
• Kyowa Kirin Korea Co., Ltd. pipeline updates RSS